UroGen Pharma URGN
NASDAQ URGN
$40.83 +0.38 (+0.94%)
As of: Sep 30, 2026 · 1:07 PM EDT

UroGen Pharma Ltd. (URGN) EBITDA (2018 - 2026)

Updated

UroGen Pharma's EBITDA was $211,000 in Q2 2026, compared with -$41.35 million a year earlier.

Analysis

UroGen Pharma Ltd. (URGN) EBITDA (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, UroGen Pharma's EBITDA was -$66.28 million through Jun 30, 2026; for FY2025, it came in at -$124.56 million.

  • In earlier years, EBITDA was -$96.45 million in FY2024, -$64.73 million in FY2023, -$78.12 million in FY2022 and -$91.46 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly EBITDA in data going back to Q1 2018.
  • Per Business Quant data, URGN's EBITDA in the three quarters before Q2 2026 was -$20.16 million (Q1 2026), -$19.04 million (Q4 2025) and -$27.29 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 211,000.00
Mar 31, 2026 -20.16 Mn
Dec 31, 2025 -19.04 Mn
Sep 30, 2025 -27.29 Mn
Jun 30, 2025 -41.35 Mn
Mar 31, 2025 -36.81 Mn
Dec 31, 2024 -27.63 Mn
Sep 30, 2024 -17.45 Mn
Jun 30, 2024 -25.74 Mn
Mar 31, 2024 -25.62 Mn
Dec 31, 2023 -14.42 Mn
Sep 30, 2023 -13.30 Mn
Jun 30, 2023 -15.18 Mn
Mar 31, 2023 -21.83 Mn
Dec 31, 2022 -20.06 Mn
Sep 30, 2022 -17.89 Mn
Jun 30, 2022 -18.52 Mn
Mar 31, 2022 -21.74 Mn
Dec 31, 2021 -19.70 Mn
Sep 30, 2021 -23.24 Mn
API Access

UroGen Pharma Ltd. EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=URGN&period=max&api_key=YOUR_API_KEY